What you need to know about the coronavirus right now
(Reuters) – Here’s what you need to know about the coronavirus right now: FILE PHOTO: Co-director of the intensive care…
AstraZeneca approached Gilead about potential merger – Bloomberg News
LONDON (Reuters) – Britain’s AstraZeneca Plc (AZN.L) has approached U.S. rival Gilead Sciences Inc (GILD.O) about a possible merger that…
U.S. CDC reports 1,891,690 coronavirus cases
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Saturday reported 1,891,690 cases of the new coronavirus,…
Fujifilm says COVID-19 drug research may drag on into July
FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed…
Shanghai Junshi Biosciences in human tests for coronavirus antibody drug
BEIJING (Reuters) – Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against…
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
SYDNEY (Reuters) – Australia’s biggest biotech firm CSL Ltd said it would help fund the development of a University of…
Michigan, California move to reopen factories as U.S. jobless ranks grow
DETROIT/SACRAMENTO, Calif. (Reuters) – Michigan and California, two U.S. manufacturing powerhouses, acted on Thursday to allow factories to reopen from…
Roche gets FDA emergency use approval for COVID-19 antibody test
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd…
CDC reports 1,031,659 coronavirus cases, 60,057 deaths
People wear masks as they walk past a closed beach during the outbreak of the coronavirus disease (COVID-19) in Del…
Diabetes, lung and heart disease common in U.S. coronavirus patients: CDC
(Reuters) – Diabetes, heart disease and long-term lung problems are the most common underlying conditions among Americans hospitalized with the…
Swiss coronavirus cases surge, canton orders seniors to stay home
ZURICH (Reuters) – Switzerland on Saturday reported 6,100 coronavirus infections, 25% more than a day earlier, and 56 deaths, the…
Germany tries to stop U.S. poaching German firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move…
Germany tries to stop U.S. from luring away firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move…
Trudeau self-isolates as wife is tested for coronavirus
OTTAWA (Reuters) – Canadian Prime Minister Justin Trudeau and his wife Sophie are in self-isolation after she came down with…
Canada’s Trudeau self-isolates as wife is tested for coronavirus
FILE PHOTO: Canada’s Prime Minister Justin Trudeau and his wife Sophie Gregoire Trudeau hold white roses as they attend a…
France’s Sanofi to carve out active drug ingredients firm
FILE PHOTO: The logo of Sanofi is seen during the annual results news conference in Paris, France, February 6, 2020.…
U.S. expands use of coronavirus diagnostic test
(Reuters) – The U.S. Food and Drug Administration on Tuesday granted emergency use approval for state public health laboratories to…
Former executive of Taro Pharmaceutical indicted in U.S. for price-fixing
WASHINGTON (Reuters) – A former sales and marketing executive of Taro Pharmaceutical Industries Ltd, Ara Aprahamian, has been indicted for…
Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed…
Health warning: How Fitbits can help predict flu outbreaks
LONDON, Jan 16 (Reuters – The Fitbit on your wrist not only counts your steps and minutes of sleep, it…
Blackstone raises three-quarters of targeted $4.6 billion life sciences fund
FILE PHOTO: The ticker and trading information for Blackstone Group is displayed at the post where it is traded on…
Explainer: Making a new generation of ‘guided-missile’ cancer drugs work
FRANKFURT (Reuters) – A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The…
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic…
Novartis, Merck and Allergan join those raising U.S. drug prices for 2020
NEW YORK (Reuters) – Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices…
Bristol-Myers wins $752 million in U.S. patent case against Gilead
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage,…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain…
CVS to increase genetic testing for some cancer patients
(This December 12 story corrects to Missouri from Montana in last paragraph) By Caroline Humer and Julie Steenhuysen NEW YORK…
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving…
U.S. FDA gives early approval to Sarepta’s newest DMD treatment
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4,…
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after…
More U.S. women know how breast density impacts cancer risk
(Reuters Health) – A growing number of U.S. women understand that breast density can impact cancer risk, but a new…
Supplements touting brain benefits may contain unauthorized ingredient
(Reuters Health) – Many supplements marketed for brain health may contain piracetam, an ingredient not proven effective for preventing or…
ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
LONDON (Reuters) – British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor,…
Novartis’s $90 million Swiss factory to help solve cell therapy bottleneck
ZURICH (Reuters) – Swiss drugmaker Novartis’s (NOVN.S) new $90 million cell and gene therapy factory in northern Switzerland is on…
AstraZeneca’s Imfinzi gets speedy FDA review for small cell lung cancer
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New…
Teva partners with Israeli institutes for early-stage drug research
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to…
Adamis shares slump as FDA declines to approve opioid overdose treatment
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid…
CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after…
New Roche flu drug can drive resistance in influenza viruses: researchers
CHICAGO (Reuters) – Roche’s influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc…
Cannabis tied to severe heart attack risk in younger adults
(Reuters Health) – Teens and young adults who use cocaine, amphetamines and cannabis are more likely to be hospitalized for…
FDA approves Aquestive’s ALS treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved bit.ly/2pIFzi5 Aquestive Therapeutics’ treatment for neurological disorder amyotrophic lateral…
Longer-term data fail to clear concern over Takeda’s dengue vaccine
CHICAGO (Reuters) – An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co’s experimental dengue vaccine…
Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end…
Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30,…
Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
ZURICH (Reuters) – Novartis AG (NOVN.S) is buying U.S. biotechnology company The Medicines Co (MDCO.O) for about $9.7 billion, the…
Roche tests ‘brain shuttle’ in humans in Alzheimer’s project
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Roche sets sights on Novartis, Biogen as SMA trial hits target
FILE PHOTO: Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration January 22,…
Roche drug for spinal muscular atrophy hits target in late-stage trial
ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on…
AstraZeneca succeeds in treating lupus in late-stage study
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock…
Merck wins European approval for first-ever Ebola vaccine
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
Juul Labs to stop sales of mint-flavored nicotine pods in U.S
(Reuters) – E-cigarette maker Juul Labs Inc will immediately stop selling its mint-flavored nicotine cartridges in the United States, the…
Britain’s AstraZeneca to distribute Sun Pharma cancer drugs in China
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble BENGALURU…
Novartis arthritis drug fails to prove it is significantly better than rival
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Amgen posts higher biosimilar sales, ends neuroscience program
(Reuters) – Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales…
J&J says new tests find no asbestos in same baby powder bottle that sparked recall
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of…
J&J says new tests find no asbestos in same baby powder bottle that sparked recall
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of…
Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics
NEW YORK (Reuters) – As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on…
Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell
LOS ANGELES/NEW YORK (Reuters) – Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby…
Two charities to pay $6 million to resolve U.S. pharma kickback probe
BOSTON (Reuters) – Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies…